Stallergenes Greer and Anergis Initiate New Study to Predict Efficacy of Second-Generation Allergen Immunotherapy
ANTONY, France & EPALINGES, Switzerland--(BUSINESS WIRE)--Oct 17, 2019--
ANTONY, France & EPALINGES, Switzerland--(BUSINESS WIRE)--Oct 17, 2019--